.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
AstraZeneca
Teva
McKinsey
Express Scripts
Medtronic
Harvard Business School
Colorcon
UBS
Julphar

Generated: February 25, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: acamprosate calcium

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Barr Labs Div TevaACAMPROSATE CALCIUMacamprosate calciumTABLET, DELAYED RELEASE;ORAL200143ANDATeva Pharmaceuticals USA, Inc.N0093-5352-86
Barr Labs Div TevaACAMPROSATE CALCIUMacamprosate calciumTABLET, DELAYED RELEASE;ORAL200143ANDAAvKARE, Inc.N42291-104-18
Glenmark GenericsACAMPROSATE CALCIUMacamprosate calciumTABLET, DELAYED RELEASE;ORAL202229ANDAMarlex Pharmaceuticals IncN10135-636-32
Glenmark GenericsACAMPROSATE CALCIUMacamprosate calciumTABLET, DELAYED RELEASE;ORAL202229ANDAAmerican Health PackagingN60687-121-25
Glenmark GenericsACAMPROSATE CALCIUMacamprosate calciumTABLET, DELAYED RELEASE;ORAL202229ANDAGlenmark Pharmaceuticals Inc., USAN68462-435-18
Glenmark GenericsACAMPROSATE CALCIUMacamprosate calciumTABLET, DELAYED RELEASE;ORAL202229ANDAGlenmark Pharmaceuticals Inc., USAN68462-435-11
Glenmark GenericsACAMPROSATE CALCIUMacamprosate calciumTABLET, DELAYED RELEASE;ORAL202229ANDAAvera McKennan HospitalE69189-0437-1
Mylan Pharms IncACAMPROSATE CALCIUMacamprosate calciumTABLET, DELAYED RELEASE;ORAL200142ANDAMylan Pharmaceuticals Inc.N0378-6333-80
Mylan Pharms IncACAMPROSATE CALCIUMacamprosate calciumTABLET, DELAYED RELEASE;ORAL200142ANDAMylan Institutional Inc.N51079-241-06
Zydus Pharms Usa IncACAMPROSATE CALCIUMacamprosate calciumTABLET, DELAYED RELEASE;ORAL205995ANDAZydus Pharmaceuticals (USA) Inc.N68382-569-06
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Deloitte
Argus Health
Chinese Patent Office
Cerilliant
Cantor Fitzgerald
UBS
Johnson and Johnson
Queensland Health
Merck

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot